| Code | 8192E | ||||||||||
| MA number | 15/0323/24-S | ||||||||||
| Product Form: | plc ifc 1x500 mg (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Adalvo Limited, Malta | ||||||||||
| Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 19.12.2024 |
| Validity: | 19.12.2029 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Dalbavancin Adalvo 500 mg prášok na koncentrát na infúzny roztok_11.2024.pdf
|
| SPC: |
SPC_Dalbavancin Adalvo 500 mg prášok na koncentrát na infúzny roztok_11.2024.pdf
|
| Safety feature | Yes |
| Data update: | 20.12.2024 |
